Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017491488> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2017491488 endingPage "223" @default.
- W2017491488 startingPage "217" @default.
- W2017491488 abstract "There is currently no established therapy for childhood IgA nephropathy (IgAN). Mizoribine, a newly developed immunosuppressive agent characterized as a safe and well-tolerated drug, has been widely used in diverse conditions. Our preliminary study demonstrated that mizoribine could reduce the amount of proteinuria in children with IgAN. The present study was conducted to confirm this finding.Ten children with IgAN (median age 13.5 years) of moderate histological severity were enrolled. None of them had been previously treated by immunosuppressants. Mizoribine was administered orally for a median period of 20.5 months. We compared the urinary protein excretion expressed as the ratio of urinary protein to urinary creatinine (UP/UC) and the hematuria evaluated as the level of occult blood by dip-stick (OB score). Renal histology was also examined in three patients using paired biopsy specimens obtained both before and after treatment. We performed blood examinations regularly to monitor the toxicity and plasma concentration of mizoribine.The median observation period was 44.5 months, consisting of a median 13.0 months before therapy, 20.5 months during therapy and 12.0 months after therapy. Significant reductions in both UP/UC and OB score were induced by mizoribine (P < 0.05). Renal mesangial proliferation was also improved. Plasma peak levels of mizoribine varied from 0.30 microg/mL to 1.23 microg/mL and were not associated with its effectiveness. No adverse effects were observed during the therapy, although a slight decrease in leukocyte count was noted.Mizoribine can be an alternative drug for childhood IgAN with moderate severity because it results in a significant reduction of proteinuria and hematuria with histological improvement and causes far fewer complications compared to the conventional immunosuppressants." @default.
- W2017491488 created "2016-06-24" @default.
- W2017491488 creator A5003529753 @default.
- W2017491488 creator A5005368084 @default.
- W2017491488 creator A5039523570 @default.
- W2017491488 creator A5067734316 @default.
- W2017491488 date "2002-03-11" @default.
- W2017491488 modified "2023-10-18" @default.
- W2017491488 title "Mizoribine treatment for childhood IgA nephropathy" @default.
- W2017491488 cites W1838497045 @default.
- W2017491488 cites W1981737785 @default.
- W2017491488 cites W1993258772 @default.
- W2017491488 cites W2001078551 @default.
- W2017491488 cites W2021397728 @default.
- W2017491488 cites W2022433281 @default.
- W2017491488 cites W2030262480 @default.
- W2017491488 cites W2032197128 @default.
- W2017491488 cites W2033008576 @default.
- W2017491488 cites W2037783818 @default.
- W2017491488 cites W2042259969 @default.
- W2017491488 cites W2073014968 @default.
- W2017491488 cites W2080764760 @default.
- W2017491488 cites W2082791667 @default.
- W2017491488 cites W2086064233 @default.
- W2017491488 cites W2093799822 @default.
- W2017491488 cites W2116086937 @default.
- W2017491488 cites W2129887999 @default.
- W2017491488 cites W2149200961 @default.
- W2017491488 cites W2951505772 @default.
- W2017491488 cites W4294187683 @default.
- W2017491488 doi "https://doi.org/10.1046/j.1328-8067.2001.01532.x" @default.
- W2017491488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11896890" @default.
- W2017491488 hasPublicationYear "2002" @default.
- W2017491488 type Work @default.
- W2017491488 sameAs 2017491488 @default.
- W2017491488 citedByCount "18" @default.
- W2017491488 countsByYear W20174914882012 @default.
- W2017491488 countsByYear W20174914882016 @default.
- W2017491488 countsByYear W20174914882017 @default.
- W2017491488 crossrefType "journal-article" @default.
- W2017491488 hasAuthorship W2017491488A5003529753 @default.
- W2017491488 hasAuthorship W2017491488A5005368084 @default.
- W2017491488 hasAuthorship W2017491488A5039523570 @default.
- W2017491488 hasAuthorship W2017491488A5067734316 @default.
- W2017491488 hasConcept C126322002 @default.
- W2017491488 hasConcept C126894567 @default.
- W2017491488 hasConcept C134018914 @default.
- W2017491488 hasConcept C159641895 @default.
- W2017491488 hasConcept C197934379 @default.
- W2017491488 hasConcept C2777882293 @default.
- W2017491488 hasConcept C2779561371 @default.
- W2017491488 hasConcept C2780026642 @default.
- W2017491488 hasConcept C2780091579 @default.
- W2017491488 hasConcept C2780306776 @default.
- W2017491488 hasConcept C2781184683 @default.
- W2017491488 hasConcept C54847362 @default.
- W2017491488 hasConcept C555293320 @default.
- W2017491488 hasConcept C71924100 @default.
- W2017491488 hasConcept C77411442 @default.
- W2017491488 hasConcept C90924648 @default.
- W2017491488 hasConceptScore W2017491488C126322002 @default.
- W2017491488 hasConceptScore W2017491488C126894567 @default.
- W2017491488 hasConceptScore W2017491488C134018914 @default.
- W2017491488 hasConceptScore W2017491488C159641895 @default.
- W2017491488 hasConceptScore W2017491488C197934379 @default.
- W2017491488 hasConceptScore W2017491488C2777882293 @default.
- W2017491488 hasConceptScore W2017491488C2779561371 @default.
- W2017491488 hasConceptScore W2017491488C2780026642 @default.
- W2017491488 hasConceptScore W2017491488C2780091579 @default.
- W2017491488 hasConceptScore W2017491488C2780306776 @default.
- W2017491488 hasConceptScore W2017491488C2781184683 @default.
- W2017491488 hasConceptScore W2017491488C54847362 @default.
- W2017491488 hasConceptScore W2017491488C555293320 @default.
- W2017491488 hasConceptScore W2017491488C71924100 @default.
- W2017491488 hasConceptScore W2017491488C77411442 @default.
- W2017491488 hasConceptScore W2017491488C90924648 @default.
- W2017491488 hasIssue "2" @default.
- W2017491488 hasLocation W20174914881 @default.
- W2017491488 hasLocation W20174914882 @default.
- W2017491488 hasOpenAccess W2017491488 @default.
- W2017491488 hasPrimaryLocation W20174914881 @default.
- W2017491488 hasRelatedWork W1972230880 @default.
- W2017491488 hasRelatedWork W1978837784 @default.
- W2017491488 hasRelatedWork W1992299009 @default.
- W2017491488 hasRelatedWork W2033008576 @default.
- W2017491488 hasRelatedWork W2035341095 @default.
- W2017491488 hasRelatedWork W2133423368 @default.
- W2017491488 hasRelatedWork W2330398643 @default.
- W2017491488 hasRelatedWork W2437876400 @default.
- W2017491488 hasRelatedWork W35851095 @default.
- W2017491488 hasRelatedWork W4384405755 @default.
- W2017491488 hasVolume "44" @default.
- W2017491488 isParatext "false" @default.
- W2017491488 isRetracted "false" @default.
- W2017491488 magId "2017491488" @default.
- W2017491488 workType "article" @default.